Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Short-Term Debt issuances: 2013-2025

Historic Short-Term Debt issuances for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Sep 2025 value amounting to $172,000.

  • Amphastar Pharmaceuticals' Short-Term Debt issuances fell 98.19% to $172,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 21.27%. This contributed to the annual value of $18.4 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Short-Term Debt issuances stood at $172,000, which was down 95.83% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Short-Term Debt issuances peaked at $500.0 million during Q2 2023, and registered a low of -$25,000 during Q2 2024.
  • Moreover, its 3-year median value for Short-Term Debt issuances was $4.1 million (2024), whereas its average is $65.5 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Short-Term Debt issuances crashed by 100.00% in 2024 and then spiked by 16,616.00% in 2025.
  • Amphastar Pharmaceuticals' Short-Term Debt issuances (Quarterly) stood at $500.0 million in 2023, then plummeted by 100.00% to $4.9 million in 2024, then slumped by 98.19% to $172,000 in 2025.
  • Its last three reported values are $172,000 in Q3 2025, $4.1 million for Q2 2025, and $1.6 million during Q1 2025.